Standout Papers
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials (2006)
- Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies (2001)
Immediate Impact
2 by Nobel laureates 5 from Science/Nature 85 standout
Citing Papers
Improved models of care for cancer survivors
2022 Standout
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis
2022 Standout
Works of Louis Denis being referenced
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
2019
Cancer survivorship: an integral part of Europe's research agenda
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Louis Denis | 2372 | 1942 | 1156 | 2227 | 94 | 5.6k | |
| Christer Busch | 3367 | 1259 | 1241 | 2488 | 102 | 6.6k | |
| Gary D. Grossfeld | 3308 | 1332 | 1117 | 1818 | 123 | 5.9k | |
| Jeffrey M. Holzbeierlein | 1498 | 779 | 1202 | 1527 | 132 | 4.3k | |
| Randall E. Millikan | 1579 | 1526 | 1229 | 2524 | 86 | 5.1k | |
| Richard Cathomas | 1244 | 1394 | 1091 | 1873 | 145 | 3.8k | |
| Louis Lacombe | 2898 | 3366 | 1624 | 2654 | 176 | 7.0k | |
| Joel W. Slaton | 1621 | 1582 | 2475 | 1908 | 117 | 5.9k | |
| Karim Chamie | 1663 | 1293 | 1336 | 2432 | 181 | 4.9k | |
| J. Edson Pontes | 3467 | 1224 | 1430 | 1848 | 155 | 5.9k | |
| C.C. Abbou | 2476 | 665 | 1999 | 2195 | 138 | 4.9k |
All Works
Loading papers...